153 related articles for article (PubMed ID: 37764419)
21. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
22. Antiproliferative, apoptosis-inducing activity and molecular docking studies of sydnones compounds.
Hossain SL; Mathews M; Bhyranalyar Nagarajappa VS; Kumar BK; Veerappa Yelamaggad CV; Singh CR
J Cancer Res Ther; 2022; 18(3):681-690. PubMed ID: 34708812
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, and Molecular Docking of Paracyclophanyl-Thiazole Hybrids as Novel CDK1 Inhibitors and Apoptosis Inducing Anti-Melanoma Agents.
Aly AA; Bräse S; Hassan AA; Mohamed NK; El-Haleem LEA; Nieger M; Morsy NM; Alshammari MB; Ibrahim MAA; Abdelhafez EMN
Molecules; 2020 Nov; 25(23):. PubMed ID: 33260954
[TBL] [Abstract][Full Text] [Related]
24. Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2',3':4,5]thiazolo[3,2-
Mourad MAE; Abo Elmaaty A; Zaki I; Mourad AAE; Hofni A; Khodir AE; Aboubakr EM; Elkamhawy A; Roh EJ; Al-Karmalawy AA
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2205043. PubMed ID: 37165800
[TBL] [Abstract][Full Text] [Related]
25. Benzoxazole-appended piperidine derivatives as novel anticancer candidates against breast cancer.
AboulWafa OM; Daabees HMG; El-Said AH
Bioorg Chem; 2023 May; 134():106437. PubMed ID: 36842320
[TBL] [Abstract][Full Text] [Related]
26. Anticancer properties of N-alkyl-2, 4-diphenylimidazo [1, 2-a] quinoxalin-1-amine derivatives; kinase inhibitors.
Rezaei Z; Mahdi Didehvar M; Mahdavi M; Azizian H; Hamedifar H; Mohammed EHM; Ostad S; Amini M
Bioorg Chem; 2019 Sep; 90():103055. PubMed ID: 31220669
[TBL] [Abstract][Full Text] [Related]
27. Antiproliferative and Pro-Apoptotic Effects of Thiazolo[3,2-b][1,2,4]triazoles in Breast and Cervical Cancer Cells.
Khan I; Zaib S; Javed M; Rashid F; Iqbal J; Ibrar A
Anticancer Agents Med Chem; 2021 Oct; 21(16):2181-2191. PubMed ID: 33573578
[TBL] [Abstract][Full Text] [Related]
28. Novel isoxazoline-linked 1,3,4-thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation.
Oubella A; Byadi S; Bimoussa A; Fawzi M; Auhmani A; Podlipnik C; Morjani H; Riahi A; Robert A; Itto MYA
Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200066. PubMed ID: 35594031
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, cytotoxic evaluation, docking and in silico pharmacokinetic prediction of 4-arylideneamino/cycloalkylidineamino 1, 2-naphthoquinone thiosemicarbazones.
Shukla S; Srivastava RS; Shrivastava SK; Sodhi A; Kumar P
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1192-8. PubMed ID: 22978426
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Anticancer and Epidermal Growth Factor Receptor Inhibition Activity by Benzochromeno Pyrimidin Derivatives in Three Human Cancer Cell Lines.
Mohammadian R; Ardestani SK; Safavi M
Med Chem; 2022; 18(6):710-723. PubMed ID: 34819010
[TBL] [Abstract][Full Text] [Related]
31. Hybrids of 1,4-Quinone with Quinoline Derivatives: Synthesis, Biological Activity, and Molecular Docking with DT-Diaphorase (NQO1).
Kadela-Tomanek M; Jastrzębska M; Chrobak E; Bębenek E; Latocha M
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234741
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization, molecular docking and anticancer studies of fluoroaniline derivatives of hydroxybenzoquinone and hydroxynaphthoquinone.
B A; Fernandez A; Laila SP; Nair AS; Vishnu VS
J Biomol Struct Dyn; 2022 Jun; 40(9):3917-3927. PubMed ID: 33314966
[TBL] [Abstract][Full Text] [Related]
33. Molecular docking studies, biological evaluation and synthesis of novel 3-mercapto-1,2,4-triazole derivatives.
Ghanaat J; Khalilzadeh MA; Zareyee D
Mol Divers; 2021 Feb; 25(1):223-232. PubMed ID: 32067134
[TBL] [Abstract][Full Text] [Related]
34. Molecular-docking-guided design, palladium-catalyzed synthesis and anticancer activity of paclitaxel-benzoxazoles hybrids.
Jiang T; Cao YN; Xu JB; Gao F; Zheng LL
Sci Rep; 2022 Jun; 12(1):10021. PubMed ID: 35705688
[TBL] [Abstract][Full Text] [Related]
35. Thiazole-Based Thiosemicarbazones: Synthesis, Cytotoxicity Evaluation and Molecular Docking Study.
Gomha SM; Abdelhady HA; Hassain DZH; Abdelmonsef AH; El-Naggar M; Elaasser MM; Mahmoud HK
Drug Des Devel Ther; 2021; 15():659-677. PubMed ID: 33633443
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents.
Hisham M; Youssif BGM; Osman EEA; Hayallah AM; Abdel-Aziz M
Eur J Med Chem; 2019 Aug; 176():117-128. PubMed ID: 31108261
[TBL] [Abstract][Full Text] [Related]
37. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
[TBL] [Abstract][Full Text] [Related]
38. Design, Synthesis, and Antiproliferative Activity of Novel Neocryptolepine-Rhodanine Hybrids.
El-Bahnsawye M; Hussein MKA; Elmongy EI; Awad HM; Tolan AAE; Moemen YS; El-Shaarawy A; El-Sayed IE
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364427
[TBL] [Abstract][Full Text] [Related]
39. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
[TBL] [Abstract][Full Text] [Related]
40. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
